InflaRx N.V.
Catalyst AI-extracted
izicopan
hidradenitis suppurativa (HS)
Resolved
110days ago
Catalyst readout · Mar 19, 2026
What's at stake A key catalyst for izicopan (hidradenitis suppurativa (HS)) is expected Mar 19, 2026.
“Substantial progress made toward Phase 2b readiness for izicopan in hidradenitis suppurativa (HS)”

Provenance

1 source on file.

Link copied ✓